Utilization management began as a cost-control tool aimed at saying no. Under value-based care its job changes: getting patients the right care, in the right place, at the right time. The distinction matters more than it sounds.
Utilization management (UM) has a reputation problem. For many patients and clinicians, it means a faceless review that delays or denies care. That reputation is not entirely unearned, but it misses what UM is actually for, and what it can become when incentives are aligned around value rather than volume.
At its core, UM is the practice of assessing whether a given service is appropriate: medically necessary, delivered in the right setting, and at the right level of care. Done well, it steers toward the care that helps and away from the care that does not, including redundant tests ordered simply because results were never shared, or a procedure when a less invasive option should come first.
Three points in time
UM happens at three moments relative to care, and each answers a different question.
- Prospective (before care): Is this service covered and necessary? Could it be done safely in a lower-cost setting? Should something be tried first? Reviewing in advance creates room for clinician-to-clinician discussion and, where needed, appeal. This is the moment most people mean when they say prior authorization.
- Concurrent (during care): Is the current level of care still right, and what comes next? This is where UM shades into care coordination, helping move a patient toward home or a less intensive setting as their needs change.
- Retrospective (after care): Was the care appropriate in hindsight, and does it match the documented diagnoses? This supports learning and accurate payment.
Most health plans ground these judgments in evidence-based guidelines, commonly MCG or InterQual, often supplemented with their own criteria for local patterns of overuse.
The shift under value-based care
In a fee-for-service world, UM is largely a brake the payer applies against a provider incentivized to do more. In a value-based arrangement, that adversarial dynamic softens, because the provider now shares responsibility for both cost and outcomes. UM’s center of gravity moves from utilization review toward care management: identifying high-need patients early, coordinating their care, and preventing the avoidable admissions and readmissions that drive both cost and harm.
A caution
None of this makes UM automatically benign. Poorly designed review still imposes administrative burden and can delay needed care, and tying it too tightly to short-term cost can tip it back toward simple denial. The test of good utilization management is not how much it withholds, but whether it reliably helps patients get the care that genuinely improves their health, and avoids the care that does not.